Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.

Published

Journal Article

OBJECTIVE: The HepatAssist liver support system is an extracorporeal porcine hepatocyte-based bioartificial liver (BAL). The safety and efficacy of the BAL were evaluated in a prospective, randomized, controlled, multicenter trial in patients with severe acute liver failure. SUMMARY BACKGROUND DATA: In experimental animals with acute liver failure, we demonstrated beneficial effects of the BAL. Similarly, Phase I trials of the BAL in acute liver failure patients yielded promising results. METHODS: A total of 171 patients (86 control and 85 BAL) were enrolled. Patients with fulminant/subfulminant hepatic failure and primary nonfunction following liver transplantation were included. Data were analyzed with and without accounting for the following confounding factors: liver transplantation, time to transplant, disease etiology, disease severity, and treatment site. RESULTS: For the entire patient population, survival at 30 days was 71% for BAL versus 62% for control (P = 0.26). After exclusion of primary nonfunction patients, survival was 73% for BAL versus 59% for control (n = 147; P = 0.12). When survival was analyzed accounting for confounding factors, in the entire patient population, there was no difference between the 2 groups (risk ratio = 0.67; P = 0.13). However, survival in fulminant/subfulminant hepatic failure patients was significantly higher in the BAL compared with the control group (risk ratio = 0.56; P = 0.048). CONCLUSIONS: This is the first prospective, randomized, controlled trial of an extracorporeal liver support system, demonstrating safety and improved survival in patients with fulminant/subfulminant hepatic failure.

Full Text

Duke Authors

Cited Authors

  • Demetriou, AA; Brown, RS; Busuttil, RW; Fair, J; McGuire, BM; Rosenthal, P; Am Esch, JS; Lerut, J; Nyberg, SL; Salizzoni, M; Fagan, EA; de Hemptinne, B; Broelsch, CE; Muraca, M; Salmeron, JM; Rabkin, JM; Metselaar, HJ; Pratt, D; De La Mata, M; McChesney, LP; Everson, GT; Lavin, PT; Stevens, AC; Pitkin, Z; Solomon, BA

Published Date

  • May 2004

Published In

Volume / Issue

  • 239 / 5

Start / End Page

  • 660 - 667

PubMed ID

  • 15082970

Pubmed Central ID

  • 15082970

International Standard Serial Number (ISSN)

  • 0003-4932

Digital Object Identifier (DOI)

  • 10.1097/01.sla.0000124298.74199.e5

Language

  • eng

Conference Location

  • United States